PAHC - Company ID 0001069899
The table below shows PHIBRO ANIMAL HEALTH CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $1.30B | $1.02B | $977.89M | $942.26M | $833.35M | $800.35M |
| Cost of revenue | $896.27M | $704.59M | $679.65M | $656.86M | $561.97M | $543.47M |
| Gross profit | $399.94M | $313.09M | $298.24M | $285.40M | $271.38M | $256.88M |
| R&D | $23.73M | $29.19M | $24.39M | $20.83M | $17.76M | $13.74M |
PHIBRO ANIMAL HEALTH CORP reported annual revenue of $1.30B for fiscal year 2025. That is up 27.4% from $1.02B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $751.53M (FY 2016) to $1.30B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $289.48M |
| $259.78M |
| $226.39M |
| $206.41M |
| $196.51M |
| $187.69M |
| Operating income | $110.47M | $53.31M | $71.85M | $78.99M | $74.87M | $69.19M |
| Income tax | $19.73M | $8.50M | $21.46M | $23.15M | $12.08M | $21.96M |
| Net income | $48.26M | $2.42M | $32.61M | $49.17M | $54.38M | $33.55M |
| EPS (diluted) | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 | $0.83 |